Ashayeri E, Dallas T, Goldson A L, Seton M, Conseption D T, Manning J C
J Natl Med Assoc. 1986 Mar;78(3):193-9.
Intraoperative radiotherapy (IOR) is a relatively new modality for the treatment of carcinoma. This modality necessitates a multidisciplinary approach among the surgeon, anesthesiologist, radiotherapist, pathologist, and other members of the surgical support team. In addition to appropriate IOR and surgical techniques, the role of the anesthesiologist is crucial in determining patient outcome. Specifically, the degree of preoperative preparation has a direct correlation with a successful postoperative course. Patients considered for surgery are grouped in terms of: (1) primary tumor with no metastasis and/or unresectable loco-regional disease; (2) clinical and investigational evidence of tumor with no proven malignancy; and (3) those with known metastasis but in otherwise good general condition.The primary surgical goal is to localize the tumor, obtain a frozen-section biopsy, and evaluate for resectability at the same time as the radiotherapist evaluates whether IOR is indicated. Thus many facets come together to make the IOR procedures feasible and safe. The 148 patients treated at Howard University Hospital, uneventfully, should serve to justify intraoperative radiotherapy as both a practical and safe tool in the treatment of malignancy.
术中放疗(IOR)是一种相对较新的癌症治疗方式。这种治疗方式需要外科医生、麻醉师、放疗师、病理学家以及手术支持团队的其他成员采取多学科方法。除了合适的术中放疗和手术技术外,麻醉师的作用对于决定患者的治疗结果至关重要。具体而言,术前准备的程度与术后过程的成功直接相关。考虑进行手术的患者分为以下几类:(1)无转移和/或不可切除的局部区域疾病的原发性肿瘤;(2)有肿瘤临床和检查证据但未证实为恶性肿瘤的患者;(3)已知有转移但总体状况良好的患者。主要手术目标是定位肿瘤、获取冰冻切片活检,并在放疗师评估是否需要进行术中放疗的同时评估肿瘤的可切除性。因此,许多方面共同作用以使术中放疗程序可行且安全。在霍华德大学医院顺利接受治疗的148例患者,应可证明术中放疗是治疗恶性肿瘤的一种实用且安全的工具。